YOLFTbeta
Raia Drogasil S.A

Raia Drogasil S.A

RADL3 · SA · Healthcare / Pharmaceutical Retailers

14.29BRL+0.03 (+0.21%)

Price History

Full chart

Market Stats

Previous Close14.26
Open14.23
Day Range14.07 – 14.42
52-Week Range16.10 – 27.13
Volume16.19M
Market Cap34.10B
P/E (TTM)22.94
Forward P/E20.20
EPS0.85
Dividend Yield2.35%
Beta0.02
50-Day Avg19.05
200-Day Avg21.15

About

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Renato Cepollina Raduan
  • Employees75.59K
  • HeadquartersAv. Corifeu de Azevedo Marques, 3097, São Paulo, SP, Brazil, 05339-900, Brazil
  • Websitehttps://rdsaude.com.br

Leadership

  • Mr. Renato Cepollina RaduanCEO & Member of Executive Board
  • Mr. Antonio Carlos CoelhoVP of Finance & Administrative and Member of Executive Board
  • Mr. Marcello De ZagottisCOO & Member of Executive Board
  • Mr. Fernando Kozel VarelaVP of Digital Transformation & Member of Executive Board
  • Mr. Bruno Wright PipponziVP of Health Business & Member of Executive Board
  • Celso Pissi FilhoAccountant & Technical Manager
  • Erika PetriVice President of People & Sustainability
  • Juliana Lopes Marques PaixaoCommercial Vice President
  • Ms. Melissa Teixeira CabralVice President of Pharmacy Operations
  • Afonso Celso Florentino de OliveiraDirector of Controllership

Financials

Income Statement

Currency: BRL2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue260.70M274.86M302.69M344.67M426.92M539.17M674.42M833.07M1.26B1.72B2.01B2.73B5.38B6.23B7.35B8.90B11.26B13.21B14.80B17.57B20.07B24.13B29.07B33.97B38.86B44.25B
Growth (%)-+5.43%+10.13%+13.87%+23.86%+26.29%+25.09%+23.52%+51.27%+36.54%+16.55%+36.09%+97.17%+15.84%+17.95%+21.04%+26.51%+17.38%+12.03%+18.67%+14.24%+20.23%+20.48%+16.88%+14.40%+13.86%
Cost of Revenue184.99M191.83M209.32M237.06M305.94M390.00M489.91M606.24M965.99M1.32B1.53B2.01B3.89B4.51B5.21B6.18B7.75B9.22B10.36B12.37B14.18B18.21B20.26B23.77B27.31B33.30B
Gross Profit---107.61M120.97M149.17M184.52M226.83M294.16M398.85M478.40M717.36M1.49B1.72B2.14B2.71B3.50B3.99B4.45B5.20B5.89B7.21B8.81B10.21B11.55B10.95B
Gross Margin---31.22%28.34%27.67%27.36%27.23%23.34%23.18%23.86%26.29%27.74%27.60%29.16%30.51%31.13%30.18%30.03%29.59%29.36%29.87%30.31%30.04%29.72%24.75%
Operating Expense---98.51M112.40M136.53M155.37M203.49M246.28M302.05M366.17M637.80M1.33B1.57B1.83B2.21B2.80B3.20B3.72B4.31B5.00B5.83B6.97B8.13B9.18B8.31B
Operating Income4.64M8.63M13.70M9.10M8.57M12.64M29.15M23.34M47.88M96.81M112.23M79.56M160.62M149.83M309.13M500.86M705.54M792.58M721.51M891.22M894.72M1.37B1.84B2.08B2.37B2.64B
Operating Margin1.78%3.14%4.53%2.64%2.01%2.34%4.32%2.80%3.80%5.63%5.60%2.92%2.99%2.40%4.20%5.63%6.27%6.00%4.87%5.07%4.46%5.69%6.33%6.12%6.09%5.96%
EBITDA---22.89M23.59M23.41M43.09M26.51M92.57M131.85M157.64M157.68M284.21M317.64M514.37M697.95M913.75M1.09B1.11B2.18B2.08B2.60B2.45B2.75B3.14B4.65B
EBITDA Margin---6.64%5.53%4.34%6.39%3.18%7.35%7.66%7.86%5.78%5.28%5.10%7.00%7.84%8.12%8.25%7.51%12.39%10.35%10.77%8.44%8.10%8.08%10.51%
Net Income1.93M5.04M8.02M6.96M7.95M9.72M20.80M21.63M51.17M74.59M89.02M68.70M104.86M100.98M221.39M340.21M447.69M511.16M502.45M772.24M484.44M751.93M996.11M1.05B1.20B1.30B
Net Income Margin0.74%1.83%2.65%2.02%1.86%1.80%3.08%2.60%4.06%4.34%4.44%2.52%1.95%1.62%3.01%3.82%3.98%3.87%3.39%4.40%2.41%3.12%3.43%3.11%3.08%2.93%
Interest Expense0000005.94M8.14M4.43M4.86M5.51M10.80M17.67M19.52M24.57M34.35M57.70M67.70M58.47M290.12M297.01M316.00M559.22M737.79M790.95M1.07B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.88%0.98%0.35%0.28%0.28%0.40%0.33%0.31%0.33%0.39%0.51%0.51%0.40%1.65%1.48%1.31%1.92%2.17%2.04%2.43%

Balance Sheet

Currency: BRL2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets134.55M137.56M153.53M166.25M194.89M225.42M299.10M567.46M596.18M730.95M922.28M3.17B3.34B3.61B4.05B4.70B5.66B6.46B7.35B12.25B13.83B14.78B17.19B20.09B22.14B25.47B
Total Liabilities49.36M50.48M61.10M69.39M93.37M158.21M177.62M198.94M240.87M319.35M323.67M967.13M1.08B1.29B1.59B2.04B2.72B3.21B3.82B8.17B9.40B10.06B11.78B14.07B15.70B18.14B
Total Equity85.19M87.08M92.43M96.87M101.53M67.22M121.48M368.52M355.31M411.60M598.62M2.20B2.26B2.33B2.46B2.63B2.91B3.22B3.50B4.03B4.36B4.68B5.34B5.96B6.43B7.32B
Cash9.14M10.09M15.78M3.56M4.84M7.57M8.79M13.58M19.78M127.69M180.85M339.97M166.96M241.88M281.19M266.05M276.63M264.87M241.57M299.23M880.36M356.12M433.54M412.32M528.00M509.62M
Total Debt----8.81M-23.72M--233.37M241.31M175.13M207.92M244.82M281.24M296.39M413.97M610.96M843.15M4.31B5.08B5.18B6.12B7.07B7.70B8.83B
Net Debt----3.56M3.97M-7.57M14.93M-13.58M-19.78M105.67M60.47M-164.85M40.96M2.94M48.00K30.34M137.34M346.09M601.58M4.01B4.20B4.82B5.62B6.66B7.17B8.32B

Cash Flow

Currency: BRL2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow8.17M17.05M18.96M15.57M11.07M16.67M16.86M28.72M-24.46M73.91M52.45M28.62M105.33M305.74M340.43M501.69M555.53M628.84M682.87M749.11M1.48B1.55B1.68B1.79B1.91B2.43B
Investing Cash Flow-----7.83M-14.65M-13.59M-32.29M-59.23M-48.43M-100.71M143.20M-257.96M-236.81M-270.97M-387.48M-489.06M-639.18M-702.97M-2.74M-673.10M-885.95M-1.23B-1.31B-1.41B-1.41B
Financing Cash Flow-----6.49M5.99M16.06M241.51M-76.74M-22.99M101.41M-12.69M-20.38M5.99M-30.15M-129.36M-55.89M-1.42M-3.20M-688.71M-223.01M-1.20B-375.25M-499.42M-383.99M-1.04B
Capital Expenditure1.06M3.54M1.99M3.69M7.69M14.33M15.14M32.94M36.18M49.53M101.58M83.70M259.64M238.21M274.65M384.85M490.17M640.33M702.99M286.65M676.42M855.60M1.19B1.30B1.28B1.40B
Free Cash Flow----3.37M2.34M1.72M-4.22M-60.38M24.38M-49.13M-55.09M-154.31M67.54M65.78M116.85M65.36M-11.49M-20.12M462.46M800.82M694.95M493.47M480.75M628.93M1.03B
Dividends Paid821.00K2.07M3.04M2.35M2.85M3.37M6.47M10.01M8.99M16.82M31.25M40.86M34.08M29.34M41.53M121.28M153.34M170.85M173.62M186.60M190.52M265.02M324.08M465.90M474.57M652.76M
FCF to OCF----30.49%14.03%10.21%-14.68%246.84%32.98%-93.68%-192.48%-146.49%22.09%19.32%23.29%11.77%-1.83%-2.95%61.74%54.21%44.82%29.33%26.93%32.88%42.28%
Dividend Paid to FCF----84.38%143.91%375.90%-237.25%-14.89%69.00%-63.61%-74.18%-22.09%43.44%63.13%103.79%234.61%-1486.92%-862.98%40.35%23.79%38.14%65.67%96.91%75.46%63.52%

Earnings

Report DateMay 14, 2009Aug 12, 2009Nov 12, 2009Mar 2, 2010May 10, 2012Aug 9, 2012Nov 13, 2012Mar 27, 2013May 29, 2013Aug 8, 2013Nov 7, 2013Mar 17, 2014May 23, 2014Aug 7, 2014Nov 6, 2014Feb 26, 2015Apr 29, 2015Jul 30, 2015Oct 29, 2015Feb 18, 2016Apr 28, 2016Jul 28, 2016Oct 27, 2016Feb 16, 2017Apr 27, 2017Jul 27, 2017Oct 26, 2017Feb 22, 2018May 3, 2018Jul 30, 2018Oct 30, 2018Feb 26, 2019Apr 29, 2019Aug 6, 2019Oct 28, 2019Feb 19, 2020Apr 28, 2020Aug 11, 2020Oct 27, 2020Mar 9, 2021May 11, 2021Aug 10, 2021Nov 8, 2021Feb 22, 2022May 3, 2022Jul 29, 2022Oct 30, 2022Mar 7, 2023May 1, 2023Aug 7, 2023Oct 30, 2023Mar 5, 2024May 6, 2024Aug 6, 2024Nov 5, 2024Feb 25, 2025May 6, 2025Aug 5, 2025Nov 4, 2025Mar 3, 2026Mar 31, 2026Aug 4, 2026Nov 3, 2026
EPS Estimate----0.010.040.030.03-0.040.02-0.020.030.030.040.150.060.050.05-0.090.070.340.060.090.080.070.370.090.070.08-0.090.080.090.080.080.110.120.100.160.110.110.080.150.120.150.110.200.140.150.140.210.170.160.140.170.210.210.170.240.26
EPS Actual0.020.020.020.020.020.030.020.020.010.030.020.020.020.040.050.040.210.070.050.060.050.100.070.310.060.080.080.080.370.080.080.090.050.090.090.190.090.030.090.140.100.130.090.120.080.200.110.180.110.190.140.170.130.110.200.320.100.220.240.180.180.21-
Surprise----100.00%-25.00%-33.33%-33.33%--25.00%0.00%-0.00%33.33%66.67%0.00%40.00%16.67%0.00%20.00%-11.11%0.00%-8.82%0.00%-11.11%0.00%14.29%0.00%-11.11%14.29%12.50%-0.00%12.50%111.11%12.50%-62.50%-18.18%16.67%0.00%-18.75%-18.18%9.09%0.00%33.33%-8.33%20.00%0.00%-5.00%0.00%13.33%-7.14%-47.62%17.65%100.00%-28.57%29.41%14.29%-14.29%1.32%-12.50%-
Timing----After-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-Pre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap34.10B
Enterprise Value42.04B
Trailing P/E22.94
Forward P/E20.20
PEG Ratio0.27
Price / Sales0.73
Price / Book4.68
EPS0.85
Book Value4.17
Revenue (TTM)46.53B
Gross Profit (TTM)14.10B
EBITDA3.86B
Profit Margin2.89%
Operating Margin7.58%
Return on Equity19.99%
Return on Assets7.80%
Shares Outstanding1.75B
Shares Float1.31B
Beta0.02
Dividend Yield2.35%
Dividend Rate0.44
Payout Ratio44.90%

Dividends

20262×
0.12Jul 3, 20260.09Apr 6, 2026
20255×
0.16Dec 5, 20250.08Oct 3, 20250.08Jul 3, 20250.06Apr 29, 20250.07Apr 3, 2025
20245×
0.07Dec 4, 20240.13Oct 3, 20240.04Jul 3, 20240.05Apr 17, 20240.05Apr 3, 2024
20235×
0.05Dec 20, 20230.05Dec 6, 20230.06Jul 5, 20230.05Apr 24, 20230.05Apr 4, 2023
20224×
0.05Dec 7, 20220.12Oct 5, 20220.04Jul 5, 20220.04Apr 4, 2022
20213×
0.06Dec 8, 20210.11Nov 12, 20210.03Jun 23, 2021

Stock Splits

  • Dec 23, 202551:50
  • May 22, 202326:25
  • Sep 21, 20205:1
  • Dec 20, 20103:1
  • Jun 14, 200720:1